Retigabine - Bausch Health Companies/GlaxoSmithKline
At a glance
- Drug Originator Meda
- Drug Licenced by Bausch Health Companies; GlaxoSmithKline
- Drug Class Antiepileptic drugs; Carbamates; Fluorobenzenes; Phenylenediamines; Small molecules
- Mechanism of Action GABA A receptor agonists; KCNQ potassium channel agonists
- USA Patent Applicants GLAXOSMITHKLINE
- NDAs 1
- Patent Applications 1,282
Table of Contents
Disclaimer